Co-Authors
This is a "connection" page, showing publications co-authored by Alexandre Cavalcanti and Fernando Zampieri.
Connection Strength
3.739
-
Hydroxychloroquine with or without Azithromycin in Covid-19. Reply. N Engl J Med. 2021 01 14; 384(2):191.
Score: 0.916
-
In Response. Anesth Analg. 2018 07; 127(1):313-314.
Score: 0.775
-
Existing capacity for renal replacement therapy and site-specific practices for managing acute kidney injury at centers participating in the BaSICS trial. Rev Bras Ter Intensiva. 2018 Jul-Sept; 30(3):264-285.
Score: 0.775
-
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19. N Engl J Med. 2020 11 19; 383(21):2041-2052.
Score: 0.223
-
Heterogeneous effects of alveolar recruitment in acute respiratory distress syndrome: a machine learning reanalysis of the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial. Br J Anaesth. 2019 07; 123(1):88-95.
Score: 0.204
-
Organizational factors associated with target sedation on the first 48 h of mechanical ventilation: an analysis of checklist-ICU database. Crit Care. 2019 Jan 29; 23(1):34.
Score: 0.202
-
Low- Versus High-Chloride Content Intravenous Solutions for Critically Ill and Perioperative Adult Patients: A Systematic Review and Meta-analysis. Anesth Analg. 2018 02; 126(2):513-521.
Score: 0.188
-
Study protocol for the Balanced Solution versus Saline in Intensive Care Study (BaSICS): a factorial randomised trial. Crit Care Resusc. 2017 Jun; 19(2):175-182.
Score: 0.180
-
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial. BMJ. 2021 01 20; 372:n84.
Score: 0.058
-
Quality of life and long-term outcomes after hospitalization for COVID-19: Protocol for a prospective cohort study (Coalition VII). Rev Bras Ter Intensiva. 2021 Jan-Mar; 33(1):31-37.
Score: 0.058
-
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial. JAMA. 2020 10 06; 324(13):1307-1316.
Score: 0.057
-
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial. Lancet. 2020 10 03; 396(10256):959-967.
Score: 0.056
-
Early goal-directed therapy using a physiological holistic view: the ANDROMEDA-SHOCK-a randomized controlled trial. Ann Intensive Care. 2018 Apr 23; 8(1):52.
Score: 0.048